First Turn Management
First Turn Management reported 31 stocks worth $935M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are RVMD (8.3%), ABVX (7.0%) and AXSM (5.7%). Compared with Q1 2026, the fund opened new positions in ASND, PCVX and RYTM, added to ABVX, AXSM and ELVN, trimmed RVMD, BBIO and UTHR and sold out of IDYA, ASND and FULC.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  RVMD Revolution Medicines Inc | $77.8M | 8.3% | 415K | −53K (−11%) | 7 of 8 | |
| 2 |  ABVX Abivax SA | $65.3M | 7.0% | 490K | +24K (+5%) | 4 of 8 | |
| 3 |  AXSM Axsome Therapeutics Inc | $53.5M | 5.7% | 218K | +30K (+16%) | 8 of 8 | |
| 4 |  ELVN Enliven Therapeutics Inc | $48.4M | 5.2% | 954K | +331K (+53%) | 7 of 8 | |
| 5 |  BBIO Bridgebio Pharma Inc | $47.2M | 5.0% | 633K | −62K (−9%) | 8 of 8 | |
| 6 |  ROIV Roivant Sciences Ltd | $47.1M | 5.0% | 1.3M | +141K (+12%) | 4 of 8 | |
| 7 |  UTHR United Therapeutics Corp Del | $46M | 4.9% | 85K | −20K (−19%) | 4 of 8 | |
| 8 |  CYTK Cytokinetics Inc | $44.9M | 4.8% | 527K | +244K (+86%) | 5 of 8 | |
| 9 |  XENE Xenon Pharmaceuticals Inc | $36.2M | 3.9% | 600K | −187K (−24%) | 8 of 8 | |
| 10 |  CELC Celcuity Inc | $34.4M | 3.7% | 329K | +119K (+56%) | 2 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 IDYA Ideaya Biosciences Inc | $29.1M | 874K |
 ASND Ascendis Pharma A/s | $17.5M | 76K |
 FULC Fulcrum Therapeutics Inc | $17.3M | 2.3M |
TERNS PHARMACEUTICALS INC | $17.2M | 327K |
 VERA Vera Therapeutics Inc | $17M | 422K |
🔒 Free account: see all 8.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →First Turn Management 13F FAQ
What does First Turn Management own?
First Turn Management reported 31 stocks worth $935M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are RVMD (8.3%), ABVX (7.0%) and AXSM (5.7%). The table above lists every position in the filing (the top 10 without an account).
What did First Turn Management buy and sell in Q2 2026?
Compared with Q1 2026: 6 new positions, 13 added to, 11 trimmed and 8 sold out. New positions include ASND, PCVX and RYTM. It sold all of IDYA, ASND and FULC.
When will First Turn Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is First Turn Management's portfolio worth?
The Q2 2026 filing reports $935M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.